The Department of Internal Medicine (DoIM) is seeking to recruit a full-time faculty member at the Assistant or Associate Professor level to join a vibrant team of physicians and scientists dedicated to preventing, understanding and treating cancer and cancer-related complications.
A PhD degree in Epidemiology or a related field is required. The Clinical Epidemiologist will support clinical research and Quality Improvement initiatives in close collaboration with physicians in the DoIM and other clinical departments. In addition, the Clinical Epidemiologist will have substantial collaboration in translational research with colleagues in Population Sciences, IT, and Biomedical Informatics, and experience in these fields is strongly preferred. The successful applicant will be expected to hybridize research and QI, and to have both a lead and collaborative role in peer-reviewed publications.
The search committee will consider clinical and translational research interests, publication record, track record of grant support, and commitment to patient care and teaching. Academic rank and compensation are dependent upon qualifications and years of experience. Faculty will be recommended for a joint appointment at the Jacobs School of Medicine, University at Buffalo.
Since 1898, Roswell Park Comprehensive Cancer Center has forged an exemplary reputation with the combined strength of its basic/translational research, multidisciplinary oncology teams, educational programs and compassionate staff. A seamless interface of scientific inquiry and clinical application and an aggressive clinical trials program, Roswell Park commits the infrastructure, intellectual capital and necessary resources to convert scientific discoveries into real-world products and applications. A charter member of the NCCN, Roswell Park is the only NCI-designated comprehensive cancer center in Upstate New York.
RPCI’s contributions to reducing the global cancer toll include initiating the world's first chemotherapy program; pioneering the prostate-specific antigen (PSA) test, photodynamic therapy and the combination chemotherapy of leucovorin and 5-FU (the gold standard for colon cancer treatment); developing the RPMI 1640 Culture Media (used in research labs around the world); and collaborating on landmark studies related to the Human Genome Project. Roswell Park initiated one of the nation's first centers dedicated to Early Phase Clinical Trials and drives innovative cancer research in genetics, cell stress and immunotherapy, leading to new personalized treatments.
Over the last decade, Roswell Park has undergone major growth, adding 1,000 new staff, showing a 198% increase in grant revenues and a 300% increase in clinical revenues, initiating one of the nation's first centers dedicated to phase I clinical research studies, and setting itself apart as a leader in surgical robotics, genetics research, vitamin D research, novel immunotherapies, and tumor microenvironment and behavior/prevention studies.
Roswell Park is an equal opportunity employer.
Candidates should email their CV and three references to:
Angela K. Gunther, MBA, AASPR
Senior Faculty Recruitment Administrator
Roswell Park Comprehensive Cancer Center